Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Change in Account Payables (2019 - 2025)

Pulmonx (LUNG) has disclosed Change in Account Payables for 7 consecutive years, with $121000.0 as the latest value for Q3 2025.

  • Quarterly Change in Account Payables fell 91.02% to $121000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Sep 2025, up 61.41% year-over-year, with the annual reading at $2.3 million for FY2024, 760.29% up from the prior year.
  • Change in Account Payables for Q3 2025 was $121000.0 at Pulmonx, down from $2.1 million in the prior quarter.
  • The five-year high for Change in Account Payables was $2.6 million in Q3 2021, with the low at -$2.8 million in Q4 2021.
  • Average Change in Account Payables over 5 years is $264894.7, with a median of $121000.0 recorded in 2025.
  • The sharpest move saw Change in Account Payables plummeted 2111.11% in 2022, then surged 42900.0% in 2025.
  • Over 5 years, Change in Account Payables stood at -$2.8 million in 2021, then skyrocketed by 70.54% to -$830000.0 in 2022, then tumbled by 104.58% to -$1.7 million in 2023, then soared by 58.78% to -$700000.0 in 2024, then skyrocketed by 117.29% to $121000.0 in 2025.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at $121000.0, $2.1 million, and $505000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.